WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded. FT reporter Anna Mutoh examines whether WeightWatchers’ latest strategy can produce the turnaround investors are hoping for.
Podden och tillhörande omslagsbild på den här sidan tillhör Financial Times. Innehållet i podden är skapat av Financial Times och inte av, eller tillsammans med, Poddtoppen.